Anne-Sophie Chretien (Anne-Sophie Chrétien, Anne Sophie Chretien, A S Chretien)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Acute Myeloid Leukemia

Top Venues

Cancer research

Proceedings of the National Academy of Sciences of the United States of America

Seminars in immunopathology

This page only lists publications with an associated author ORCID identifier.

Publications

Anne CharlotteLe Floch Le Floch, Florence Orlanducci, Marie Christine Bene, Amira Ben Amara, Marie-Sarah Rouvière, Nassim Salem, Aude Le Roy, Charlotte Cordier, Clémence Demerlé, Samuel Granjeaud, Jean-François Hamel, Norbert Ifrah, Pascale Cornillet-Lefebvre, Jacques Delaunay, Christian Recher, Eric Delabesse, Arnaud Pigneux, Norbert Vey, Anne-Sophie Chretien, Daniel Olive
Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemia. Blood advances 8 (16) (2024)
Anne CharlotteLe Floch Le Floch, Florence Orlanducci, Marie Christine Bene, Amira Ben Amara, Marie-Sarah Rouvière, Nassim Salem, Aude Le Roy, Charlotte Cordier, Clémence Demerle, Samuel Granjeaud, Jean-François Hamel-Broza, Norbert Ifrah, Pascale Cornillet-Lefebvre, Jacques Delaunay, Christian Recher, Eric Delabesse, Arnaud Pigneux, Norbert Vey, Anne-Sophie Chretien, Daniel Olive
Low frequency of Vγ9Vδ2 T-cells predicts poor survival in newly diagnosed acute myeloid leukemia. Blood advances (2024)
Anne CharlotteLe Floch Le Floch, Florence Orlanducci, Marie Christine Bene, Amira Ben Amara, Marie-Sarah Rouvière, Nassim Salem, Aude Le Roy, Charlotte Cordier, Clémence Demerlé, Samuel Granjeaud, Jean-François Hamel, Norbert Ifrah, Pascale Cornillet-Lefebvre, Jacques Delaunay, Christian Recher, Eric Delabesse, Arnaud Pigneux, Norbert Vey, Anne-Sophie Chretien, Daniel Olive
Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemia. Blood advances 8 (16) (2024)
Stéphane Fattori, Aude Le Roy, Jemila Houacine, Lucie Robert, Riad Abes, Laurent Gorvel, Samuel Granjeaud, Marie-Sarah Rouvière, Amira Ben Amara, Nicolas Boucherit, Carole Tarpin, Jihane Pakradouni, Emmanuelle Charafe-Jauffret, Gilles Houvenaeghel, Eric Lambaudie, François Bertucci, Philippe Rochigneux, Anthony Goncalves, Arnaud Foussat, Anne-Sophie Chretien, Daniel Olive
CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer. Cancer research (2023)
Sumin Jo, Shipra Das, Alan Williams, Anne-Sophie Chretien, Thomas Pagliardini, Aude Le Roy, Jorge Postigo Fernandez, Diane Le Clerre, Billal Jahangiri, Isabelle Chion-Sotinel, Sandra Rozlan, Emilie Dessez, Agnes Gouble, Mathilde Dusséaux, Roman Galetto, Aymeric Duclert, Emanuela Marcenaro, Raynier Devillier, Daniel Olive, Philippe Duchateau, Laurent Poirot, Julien Valton
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing. Nature communications 13 (1) (2022)
Philippe Rochigneux, Aaron E Lisberg, Alejandro Garcia, Samuel Granjeaud, Anne Madroszyk, Stéphane Fattori, Anthony Goncalves, Raynier Devillier, Pauline Maby, Nassim Salem, Laurent Gorvel, Brice Chanez, Jaklin Gukasyan, James Carroll, Jonathan Wade Goldman, Anne-Sophie Chretien, Daniel Olive, Edward B Garon
Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Stéphane Fattori, Hugo Roux, Emilie Connen, Lucie Robert, Laurent Gorvel, Aude Le Roy, Jemila Houacine, Arnaud Foussat, Anne-Sophie Chretien, Daniel Olive
Therapeutic Targeting of Tumor-Infiltrating Regulatory T Cells in Breast Cancer. Cancer research 82 (21) (2022)
J Wlosik, S Fattori, P Rochigneux, A Goncalves, D Olive, Anne-Sophie Chretien
Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy. Seminars in immunopathology (2022)
Anne-Sophie Chretien, Raynier Devillier, Samuel Granjeaud, Charlotte Cordier, Clemence Demerle, Nassim Salem, Julia Wlosik, Florence Orlanducci, Laurent Gorvel, Stephane Fattori, Marie-Anne Hospital, Jihane Pakradouni, Emilie Gregori, Magali Paul, Philippe Rochigneux, Thomas Pagliardini, Mathieu Morey, Cyril Fauriat, Nicolas Dulphy, Antoine Toubert, Herve Luche, Marie Malissen, Didier Blaise, Jacques A Nunès, Norbert Vey, Daniel Olive
High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome. Proceedings of the National Academy of Sciences of the United States of America 118 (22) (2021)